Abstract
IN A WELCOME boost, Ireland is seeing a wave of biotechnology investments and new companies. With pharmaceutical and chemical products making up more than 50% of Irish exports, such developments are vital to the country’s economy. Pfizer says it will invest $200 million to expand its Grange Castle biotech manufacturing facility near Clondalkin. The site is already Pfizer’s largest investment in Ireland and the only facility in Europe to manufacture biopharmaceuticals, pharmaceuticals, and vaccines at one location, the company says. The move, Pfizer adds, will strengthen its manufacturing and supply network. According to the industrial development agency IDA Ireland , Pfizer is Ireland’s largest pharmaceutical investor, having spent more than $7 billion there. But Pfizer has been shedding other Irish operations. In March it sold its Dun Laoghaire biologics formulation and fill facility to Amgen. Three months later its bulk biologics plant in Shanbally went to BioMarin Pharmaceutical Meanwhile, mergers invo...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
